Kenneth J. Hillan
CIK 1600359 · Chief Therapeutics Officer · last filed 2025-06-16
Kenneth J. Hillan is a Chief Therapeutics Officer who has filed 35 SEC Form 4 insider transactions across 5 companies since 2015. The most recent filing, for SGMO, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$295.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
35
-$295.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 99,600 | $0.18 | $17.7K | $0 | 6 | 2025-06-16 |
| ZYME | Director | — | $22.88 | — | $0 | 5 | 2023-12-08 |
| Chrome Holding Co. (ME) Delisted | Chief Therapeutics Officer | 237,223 | $0.61 | $143.8K | -$31.9K | 8 | 2023-06-07 |
| Achaogen, Inc. (AKAO) Delisted | See Remarks | 293,336 | — | — | -$244.3K | 12 | 2018-06-29 |
| Relypsa Inc (RLYP) Delisted | Director | 2,250 | — | — | -$19.6K | 4 | 2016-09-02 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-06-06 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2023-12-08 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2023-06-07 | Chrome Holding Co. (ME) Delisted | Mixed | +29,034 | -$31.9K | EDGAR |
| 2023-06-05 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +13,900 | $0 | EDGAR |
| 2023-05-23 | Chrome Holding Co. (ME) Delisted | Tax (F) | −4,628 | -$9.0K | EDGAR |
| 2023-02-22 | Chrome Holding Co. (ME) Delisted | Tax (F) | −5,457 | -$15.7K | EDGAR |
| 2022-12-23 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2022-11-22 | Chrome Holding Co. (ME) Delisted | Tax (F) | −4,628 | -$13.8K | EDGAR |
| 2022-08-25 | Chrome Holding Co. (ME) Delisted | Sell (S) | −8,753 | -$31.9K | EDGAR |